|
拾、參考文獻
Aldape K., Huizinga H., Bouvier J., and McKerrow J. 1994. Naegleria fowleri: characterization of a secreted histolytic cysteine protease. Exp Parasitol. 78: 230-241.
Alicata J.E. 1965. Biology and distribution of the rat lungworm, Angiostrongylus cantonensis and its relationship to eosinophilic meningoencephalitis and other neurological disorders of man and animals. In: Advances in parasitology. (Dawes, B. et al), Academic press, London and New York: pp. 223-248.
Andreasen P.A. Kjoller L., Christensen L., and Duffy M.J. 1997. The urokinasetype plasminogen activator system in cancer metastasis: a review. Int J Cancer. 72: 1-22.
Ash L.R., 1970. Diagnostic morphology of the third-stage larvae of Angiostrongylus cantonensis, Angiostrongylus vasorum, Aelurostrongylus abstrusus, and Anafilaroides rostratus (Nematoda: Metastrongyloidea). J Parasitol. 56: 249-253.
Backstrom J.R., Miller C.A., and Tokes Z.A. 1992. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. J Neurochem. 58: 983-992.
Barten D.M., and Ruddle N.H. 1994. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis. J Neuroimmunol. 51:123-133.
Basset P., Okada A., Chenard M.P., Kannan R., Stoll I., Anglard P., Bellocq J.P., and Rio M.C. 1997. Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 15: 535-541.
Betsuyaku T., Fukuda Y., Parks W.C., Shipley J.M., and Senior R.M. 2000. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am J Pathol. 157: 525-535.
Blasi F. 1997. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways ? Review. Immunol Today. 18: 415-417.
Blood C.H., and Zetter B.R. 1990. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta. 1032: 89-118.
Bottomley K.M., Johnson W.H., and Walter D.S. 1998. Matrix metalloproteinase inhibitors in arthritis. J Enzyme Inhib. 13: 79-101.
Bradbury M.W. 1985. The blood-brain barrier. Transport across the cerebral endothelium. Circ Res. 57: 213-22.
Brew K., Dinakarpandian D., and Nagase H. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta. 1477: 267-283.
Brightman M.W. and Reese T.S. 1969. Junction between intimately apposed cell membranes in the vertebrate brain. J cell Biol. 40: 648-677.
Broadwell R.D., Baker-Cairns B.J., Friden P.M., Oliver C., and Villegas J.C. 1996. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Exp Neurol. 142: 47-65.
Busch E., Kruger K., Fritze K., Allegrini P.R., Hoehn-Berlage M., and Hossmann K.A. 1997. Blood-brain barrier disturbances after rt-PA treatment of thromboembolic stroke in the rat. Acta Neurochir Suppl. 70: 206-208.
Carmeliet P., Moons L., Lijnen R., Baes M., Lemaitre V., Tipping P., Drew A., Eeckhout Y., Shapiro S., Lupu F., and Collen D. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet. 17: 439-444.
Carroll P.M., Tsirka S.E., Richards W.G., Frohman M.A., and Strickland S. 1994. The mouse tissue plasminogen activator gene 5-flanking region directs appropriate expression in development and seizure-enhanced response in the CNS. Development. 120: 3173-3183.
Chang P.K., and Cross J.H. 1966. Eosinophilic meningoencephalitis cause by Angiostrongylus cantonensis: Report of a human infection and a new intermediate host. J. Formosan. Med Assoc. 65: 637-638.
Chen E.R. 1979. Angiostrongylosis and eosinophilic meningitis on Taiwan: a review. In: J. H. Cross (Ed.) , Studies on Angiostrongyliasis in Eastern Asia and Australia. Taipei, Taiwan, U.S. Naval Medical Research Unit No. 2, NAMRU-2-SP-44: pp. 57-73.
Chen E.R., Hsieh H.C., and Shih C.C. 1971. First report on biological study of Achatina fulica (an intermediate host of Angiostrongylus cantonensis) in south Taiwan. J Formosa Med Assoc. 70: 364.
Chen H.T. 1933. A preliminary report on a survey of animal parasities of Canton, China, rat. Lingnan Sci J. 12: 65-74.
Chen K.M., Lee H.H., Lu K.H., Tseng Y.K., Hsu L.S., Chou H.L., and Lai S.C. 2004. Association of matrix metalloproteinase-9 and Purkinje cell degeneration in mouse cerebellum caused by Angiostrongylus cantonensis. Int J Parasitol. 34: 1147-1156.
Chen S.N. 1972. A survey of Angiostrongylus cantonensis, in rodents and snails on Pescadores Islands (Peng-hu). Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 5: 129.
Chiu J.K. 1964. Snail hosts of Angiostrongylus cantonensis in Taipei, Taiwan. Bull Inst Zool Acad Sin. 3: 55-62.
Collen D. 1999. The plasminogen (fibrinolytic) system. Thromb Haemost. 82: 259-270.
Collen D., and Lijnen H.R. 1991. Basic and clinical aspects of fibrinolysis and thombolysis. Blood. 78: 3114-3124.
Cre´ange A., Sharshar T., Planchenault T., Christov C., Poron F., Raphae¨l, J.C., and Gherardi R.K. 1999. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barre´ syndrome. Neurology 53: 1683-1691.
Cross J.H. 1967. Review of Angiostrongyliasis in Taiwan . Seminar on helminthiases and eosinophilic meningitis, South Pacific Commission, Noumea, New Caledonia. 7.
Cuzner M.L., and Opdenakker G. 1999. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J Neuroimmunol. 94: 1-14.
Damjanov I., McCue P.A., and Chansky M. 1996. Nervous system. In: Histopathology a Color Atlas. and Textbook. (ed. J. Velker). New York, USA: Williams & Wilkins, pp. 459-489.
Dano K., Andreasen P.A., Grondahl-Hansen J., Kristensen P., Nielsen L. S., and Skriver L. 1985. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44: 139-266.
Davson H., and Segal M.B. 1995. The Proteins and other macromolecules of the CSF. In: Physiology of the CSF and of the Blood-Brain Barrier. (eds H. Davson, M.B. Segal). New York: CRC, pp. 573-606.
Dhawan S., Weeks B.S., Soderland C., Schnaper H.W., Toro L.A., Asthana S.P., Hewlett I.K., Stetler-Stevenson W.G., Yamada S., Yamada K., and Meltzer M.S. 1995. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol. 154: 422-432.
Dorta-Contreras A.J, and Reiber H. 1998. Intrathecal synthesis of immunoglobulins in eosinophilic meningoencephalitis due to Angiostrongylus cantonensis. Clin Diagn Lab Immunol.5: 452-455.
Dougherty E.C. 1946. The genes Aelurostrongylus Cameron, 1927(Nematoda: Metastrongylodae), and its relatives, with the description of Parafilaroides, gen. nov. and Angiostrongylus gubermaculatus, sp. Nov. Proc. Helminth Soc. Wash. 13: 16-26.
Drews L.R. 1998. Biology of the blood-brain glucose transporter. In: Introduction to the blood-brain barrier. Methodology, biology and pathology. Pardridge W.M. (ed). Cambridge University Press. Cambridge. pp. 165-174.
Duffy T.C., Kirby R., and Rudloff E. (2004) Critical role of the vascular endothelial cell in health and disease: a review article. J. Vet. Emerg. Crit. Care. 14: 84-99.
Duffy M.J. 2004. The urokinase plasminogen activator system: role in malignancy. Curr Pharm Des. 10: 39-49.
Estreicher A., Muhlhauser J., Carpentier J.L., Orci L., and Vassalli J.D. 1990. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 111: 783-792.
Farrell C.L., and Shivers R.R. 1984. Capillary junctions of the rat are not affected by osmotic opening of the blood-brain barrier. Acta Neuropathol (Berl). 63: 179-189.
Galardy R.E., Cassabonne M.E., Giese C., Gilbert J.H., Lapierre F., Lopez H., Schaefer M.E., Stack R., Sullivan M., and Summers B. 1994. Low molecular weight inhibitors in corneal ulceration. Ann NY Acad Sci. 732: 315-323.
Gardiner C.H., Well S., Gutter A.E., Fitzgerald L., Anderson D.C., Harris R.K., and Nichols D.K. 1990. Eosinophili meningocephalitis due to Angiostrongylus cantonensis as the cause of death in captive non-human primates. Am J Trop Med Hyg. 4: 70-74.
Ghose A.K., Viswanadhan V.N., and Wendoloski J.J. 1999. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1: 55-68.
Gijbels K., Galardy R.E., and Steinman L. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest. 94: 2177-2182.
Gijbels K., Masure S., Carton H. and Opdenakker G. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol. 41: 29-34.
Giraudon P., Buart S., Bernard A., and Belin M.F. 1997. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes. Mol Psychiatry. 2: 107-110.
Goetzl E.J., Banda M.J., and Leppert D. 1996. Matrix metalloproteinases in immunity. J Immunol. 156: 1-4.
Goldmann E.E. 1913. Vitäfarbung am Zentralnervensystem. Abh Preuss Akad Wiss Phys-Math. 1: 1-60.
Gomez D.E., Alonso D.F., Yoshiji H., and Thorgeirsson U.P. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 74: 111-122.
Herron G.S., Werb Z., Dwyer K., and Banda M.J. .1986. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem. 261: 2810-2813.
Hou R.F., Tua W.T., Lee H.H., Chen K.M., Chou H.L., and Lai S.C. 2004. Elevation of plasminogen activators in cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Int J Parasitol. 34: 1355-1364.
Hsu W.T., Chen J.Y., Chien C.T., Chi C.S., and Han N.T. 1990. Eosinophilic meningitis caused by Angiostrongylus cantonensis. Pediatr Infect Dis J. 9: 443-445.
Hwung T.P., and Chen E.R. 1988. Angiostrongyliasis (Angiostrongylus cantonensis): Handbook of Clinical Neurology ; 8: (52): Microbial Disease (Harris, A. A. Ed.) Elsevier Science Publishers B.V. pp. 545-562.
Ijichi A., Sakuma S., and Tofilon P.J. 1995. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia. 14: 87-93.
Indyk J.A., Chen Z.L., Tsirka S.E., and Strickland S. 2003. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury. Neuroscience. 116: 359-371.
Jindrak K., and Alicata J.E. 1968. Comparative pathology in experimental infection of pigs and calves with larvae of Angiostrongylus cantonensis. J Comp Pathol. 78: 371-382.
Johnsen M., Lund L.R., Romer J., Almholt K., and Dano K. 1998. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol. 10: 667-671.
Kaczmarek L., Lapinska-Dzwonek J., and Szymczak S. 2002. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? New EMBO member’s review. EMBO J. 21: 6643-6648.
Kapural M., Krizanac-Bengez L.j., Barnett G., Perl J., Masaryk T., Apollo D., Rasmussen P., Mayberg M.R., and Janigro D. 2002. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 940: 102-104.
Kataoka K., Asai T., Taneda M., Ueshima S., Matsuo O., Kuroda R., Kawabata A. and Carmeliet P. 2000. Roles of urokinase type plasminogen activator in a brain stab wound. Brain Res. 887: 187-190.
Khuth S.T., Akaoka H., Pagenstecher A., Verlaeten O., Belin M.F., Giraudon P., and Bernard A. 2001. Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol. 75: 8268-8282.
Kieseier B.C., Clements J.M., Pischel H.B., Wells G.M., Miller K., Gearing A.J., and Hartung H.P. 1998. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and Guillain-Barre syndrome. Ann Neurol. 43: 427-434.
Kieseier B.C., Paul R., Koedel U., Seifert T., Clements J.M., Gearing A.J., Pfister H.W., and Hartung H.P. 1999. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain. 122: 1579-1587.
Kleiner D., and Stetler-Stevenson W. 1999. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 43: S42-S51.
Kliks M.M., Kroenke K., and Hardman J.M. 1982. Eosinophilic radiculomyeloencephalitis: an angiostrongyliasis outbreak in American Samosa related to ingestion of achatina fulica snails. Am J Trop Hyg. 31: 1114-1122.
Kolb S.A., Lahrtz F., Paul R., Leppert D., Nadal D., and Pfister H.W. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol. 84: 143-150.
Kouwenhoven M., Ozenci V., Gomes A., Yarilin D., Giedraitis V., Press R., and Link H. 2001. Multiple sclerosis: elevated expression of matrix metalloproteinases in blood monocytes. J Autoimmun. 16: 463-470.
Kuberski M.D., and Wallace G.D. 1979. Clinical manifestations of eosinophilic meningitis due to Angiostrongylus cantonensis. Neurology. 29: 1566-1570.
Kullich W.C., Mur E., Aglas F., Niksic F., and Czerwenka C. 2006. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis. Clin Exp Rheumatol. 24: 155-160.
Lai S.C., Twu J.J., Jiang S.T., Hsu J.D., Chen K.M., Chiaing H.C., Wang C.J., Tseng C.K., Shyu L.Y., and Lee H.H. 2004. Induction of matrix metalloproteinase-9 in murine eosinophilic meningitis caused by Angiostrongylus cantonensis. Ann Trop Med Parasitol. 98: 715-724.
Lan K.P., Wang C.J., Hsu J.D., Chen K.M., Lai S.C., Lee H.H. 2004. Induced eosinophilia and proliferation in Angiostrongylus cantonensis-infected mouse brain are associated with the induction of JAK/STAT1, IAP/NF-kappaB and MEKK1/JNK signals. J Helminthol. 78: 311-317.
Lebeurrier N., Liot G., Lopez-Atalaya J.P., Orset C., Fernandez-Monreal M., Sonderegger P., Ali C., and Vivien D. 2005. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci. 30: 552-558.
Lee H.H., Chou H.L., Chen K.M., and Lai S.C. 2004. Association of matrix-metalloproteinase-9 in eosinophilic meningitis of BALB/ c mice caused by Angiostrongylus cantonensis. Parasitol Res. 94: 321-328.
Lee S.R., and Lo E.H. 2004. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J Cereb Blood Flow Metab. 24: 720-727.
Leeson T.S., and Leeson C.R. 1970. Urinary system. In: Histology. Leeson T.S. and Leeson C.R. (eds). W.B. Saunder Co. Philadephla. pp. 368-369.
Leib S.L, Clements J.M., Lindberg R.L., Heimgartner C., Loeffler J.M., Pfister L.A, Täuber M.G., and Leppert D. 2001. Inhibition of MMP and TNF-α converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain. 124: 734-742.
Leib S.L., and Täuber M.G. 1999. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am. 13: 527-548.
Leppert D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., Miller K. M., Hauser S.L., and Kappos L. 1998. Matrix metalloproteinases-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain. 121: 2327-2334.
Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., and Holländer G.A. 2000. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis. 31: 80-84.
Leppert D., Lindberg R.L., Kappos L., and Leib S.L. 2001. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev. 36: 249-257.
Lim G.P., Backstrom J.R., Cullen M.J., Miller C.A., Atkinson R.D., and Tokes Z.A. 1996. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J Neurochem. 67: 251-259.
Lindo J.F., Waugh C., Hall J., Cunningha-Myrie C., Ashley D., Eberhard M.L., Sullivan J.J., Bishop H.S., Robinson D.G., Holtz T., and Robinson R.D. 2002. Enzootic Angiostrongulus cantonensis in rats and snails after an outbreak of human eosinophilic meningitis, Jamaica. Emerg Infect Dis. 8: 423-326.
Lo E.H., Wang X., and Cuzner M.L. 2002. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res. 69: 1-9.
Lohmann C., Krischke M., Wegener J., and Galla H.J. 2004. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res. 995: 184-196.
Lorenzl S., Albers D.S., Narr S., Chirichigno J., and Beal M.F. 2002. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson’s disease. Exp Neurol. 178: 13-20.
Lossinsky A.S., and Wisniewski H.M. 1998. Immunoultrastructural expression of ICAM-1 and PECAM-1 occurs prior to structural maturity of the murine blood-brain barrier. Dev Neurosci. 20: 518-524.
Lossinsky A.S., Garcia J.H., Iwanowski L., and Lightfoote W.E. 1979. New ultrastructural evidence for a protein transport system in endothelial cells of gerbil brains. Acta Neuropathol (Berl). 47: 105-110.
Lukes A., Mun-Bryce S., Lukes M., and Rosenberg G.A. 1999. Extracellular matrix degradation by metalloproteinases and central nervous system diseases. Mol Neurobiol. 19: 267-284.
Mackerras M.J., and Sandars D.F. 1955. The life history of the rat lungworm, Angiostrongylus cantonensis (chen)(Nematoda: Metastrongyloidea). Aust J Zool. 3: 1-25.
Majno G. 1965. Ultrastructure of the vascular membrane. In: Handbook of physiology Sec. 2. Hamilton W.F. and Dow P. (eds). Hamilton. Washington, D.C. pp. 2293-2375.
Marchesi V.T. 1961. The site of leucocyte emigration during inflammation. Q J Exp Physiol Cogn Med Sci. 46: 115-118.
Marchi N., Fazio V., Cucullo L., Kight K., Masaryk T., Barnett G., Vogelbaum M., Kinter M., Rasmussen P., Mayberg M.R., and Janigro D. 2003. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J Neurosci. 23: 1949-1955.
Martin T.J., Allan E.H., and Fukumoto S. 1993. The plasminogen activator and inhibitor system in bone remodelling. Growth Regul. 3: 209-214.
Matsumoto T. 1937. Nematode found in lung, especially in the pulmonary artery of the wild rat. Taiwan Igakai Zasshi. 36: 32-35.
Matsuura E., Umehara F., Hashiguchi T., Fujimoto N., Okada Y., and Osame M. 2000. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci. 173: 45-52.
Matute C., Alberdi E., Ibarretxe G., and Sanchez-Gomez M.V. 2002. Excitotoxicity in glial cells. Eur J Pharmacol. 447: 239-246.
Meeusen E.N., and Balic A. 2000. Do eosinophilis have a role in the killing of helminth parasites？Parasitol Today. 16: 95-101.
Megarbane B., Marchal P., Marfaing-Koka A., Belliard O., Jacobs F., Chary I. and Brivet F.G. 2004. Increased diffusion of soluble adhesion molecules in meningitis, severe sepsis and systemic inflammatory response without neurological infection is associated with intrathecal shedding in cases of meningitis. Intensive Care Med. 30: 867-874.
Mun-Bryce S., and Rosenberg G.A. 1998. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol. 274: R1203-R1211.
Mun-Bryce S., Lukes A., Wallace J., Lukes-Marx M., and Rosenberg G.A. 2002. Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res. 933: 42-49.
Murphy F.R., Issa R., Zhou X., Ratnarajah S., Nagase H., Arthur M.J., Benyon C., and Iredale J.P. 2002. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition. Implications for reversibility of liver fibrosis. J Biol Chem. 277: 11069-11076.
Murphy G., Willenbrock F., Ward R., O’Shea M., and Docherty A. 1993. Studies on the structure and function of the matrix metalloproteinases and their inhibitors, in: Bond, J.S., Barrett, A.J. (Eds.), Proteolysis and Protein Turnover. Portland Press, London, pp. 25-32.
Nagase H. 1997. Activation mechanism of matrix metalloproteinases. Biol Chem. 378: 151-160.
Nagase H., and Woessner J.F. 1999. Matrix metalloproteinases: a mini review. J Biol Chem. 274: 21491-21494.
Nagase H., Meng Q., Malinovskii V., Huang W., Chung L., Bode W., Maskos K., and Brew K. 1999. Engineering of selective TIMPs. Ann N Y Acad Sci. 878: 1-11.
Nakagawa T., Kubota T., Kabuto M., Sato K., Kawano H., Hayakawa T., and Okada Y. 1994. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg. 81: 69-77.
Niedbala M.J. 1993. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl. 42: 179-93.
Nielsen B.S., Timshel S., Kjeldsen L., Sehested M., Pyke C., Borregaard N., and Dano K. 1996. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer. 65: 57-62.
Ning M., Furie K.L., Koroshetz W.J., Lee H., Barron M., Lederer M., Wang X., Zhu M., Sorensen A.G., Lo E.H., and Kelly P.J. 2006. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology. 66: 1550-1555.
Nishimura K., and Hung T. 1997. Current views on geographic distribution and modes of infection of neurohelminthic diseases. J Neurol Sci. 145: 5-14.
Nomura S., and Lin P.H. 1945. The first human case infected with Haemostrongylus ratti. Taiwan No Ikai. 3: 589-592.
Norenberg M.D. 1994. Astrocyte responses to CNS injury. J Neuropathol Exp Neurol. 53: 213-220.
Okada S., Kita H., George T.J., Gleich G.J., and Leiferman K.M. 1997. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol. 17: 519-528.
Ossowski L. 1988. Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell. 52: 321-328.
Parsons J.C., and Grieve R.B. 1990. Effect of egg dosage and host genotype on liver trapping in murine larval toxocariasis. J Parasitol. 76: 53-58.
Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., and Pfister H.W. 1998. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol. 44: 592-600.
Perez O., Capron M., Lastre M., Venge P., Khalife J. and Capron A. 1989. Angiostrongylus cantonensis: role of eosinophils in the neurotoxic syndrome (Gordon-like phenomenon). Exp Parasitol. 68: 403-413.
Peters A., Palay S.L. and Webster H. 1976. Blood vessels. In: The fine structure of the nervous system: The neurons and supporting cells. Peters A., Palay S.L. and Webster H. def. 9eds). W.B. Saunders Co. Philadelphia. pp. 296-305.
Phelps C.H. 1972. The development of glio-vascular relationships in the rat spinal cord. An electron microscopic study. Z Zellforsch Mikrosk Anat. 128: 555-63.
Ploug M., and Ellis V. 1994. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins. FEBS Lett. 349: 163-168.
Pluskota E., Soloviev D.A., and Plow E.F. 2003. Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood. 101: 1582-1590.
Price N.M., Farrar J., Chau T.T.H., Mai N.T.H., Hien T.T., and Friedland J.S. 2001. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol. 166: 4223-4230.
Rabbani S.A., Mazar A.P., Bernier S.M., Haq M., Bolivar I., Henkin J., and Goltzman D. 1992. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J Biol Chem. 267: 14151-14156.
Raghow R. 1994. The role of matrix metalloproteinases in postinflammatory wound healing and fibrosis. FASEB J. 8: 823-831.
Ramirez F., and Rifkin D.B. 2003. Cell signaling events: a view from the matrix. Matrix Biol. 22: 101-107.
Reese T.S., and Karnovsky M.J. 1967. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol. 34: 207-217.
Reiber H. 1994. Flow rate of cerebrospinal fluid (CSF)- a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci. 122: 189-203.
Reiber H. 2003. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 21: 79-96.
Ridet J.L., Malhotra S.K., Privat A., and Gage F.H. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577.
Risau W. and Wolburg H. 1990. Development of the blood-brain barrier. Trends Neurosci. 13: 174-178.
Rosenberg G.A. 1995. Matrix metalloproteinases in brain injury. J Neurotrauma. 12: 833-842.
Romanic A.M, and Madri J.A. 1994. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4: 145-156.
Rooprai H.K., and McCormick D. 1997. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res. 17: 4151-4162.
Rosen L., Loison G., Laigret J., and Wallace G.D. 1967. Studies on eosinophilic meningitis. Epidemiologic and clinical observations on Pacific islands and the possible etiologic role of Angiostrongylus cantonensis. Am J Epidemiol. 85: 17-44.
Rosenberg G.A. 1995. Matrix metalloproteinases in brain injury. J. Neurotrauma. 12: 833-842.
Rothenberg M.E., Owen W.F., Silberstein D.S., Woods J., Soberman R.J., Austen K.F., and Stevens R.L. 1998. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest. 81: 1986-92.
Sappino A.P., Madani R., Huarte J., Belin D., Kiss J.Z., Wohlwend A., and Vassalli J.D. 1993. Extracellular proteolysis in the adult murine brain. J Clin Invest. 92: 679-685.
Sasaki D., Sugaya H., Ishida K., and Yoshimura K. 1993. Ablation of eosinophils with anti-IL-5 antibody enhances the survival of intracranial worms of Angiostrongylus cantonensis in mouse. Parasite Immunol. 15: 349-354.
Seeds N.W., Basham M.E., and Haffke S.P. 1999. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci U S A. 96: 14118-14123.
Shapiro S.D. 1998. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol. 10: 602-608.
Shen G.X. 1998. Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders. Int J Mol Med. 1: 399-408.
Simon H.U., Yousefi S., Schranz C., Schapowal A., Bachert C. and Blaser K. 1997. Direct demonstration of delayed eosionphil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 158: 3902-3908.
Smith P.C., Muñoz V.C., Lollados L., and Oyarzún A.D. 2004. In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease. J Periodont Res. 39: 87-92.
Smith Q.R., Johanson C.E., and Woodbury D.M. 1981. Uptake of 36Cl and 22Na by the brain-cerebrospinal fluid system: comparison of the permeability of the blood-brain and blood-cerebrospinal fluid barriers. J Neurochem. 37: 117-24.
Stubbs M.T, Renatus M., and Bode W. 1998. An active zymogen: unravelling the mystery of tissue-type plasminogen activator. Biol Chem. 379: 95-103.
Sugaya H., and Yoshimura K. 1988. T-cell-dependent eosinophilia in the cerebrospinal fluid of the mouse infected with Angiostrongylus cantonensis. Parasite Immunol. 10: 127-138.
Sugaya H., Aoki M., Yoshida T., Takatsu K. and Yoshimura K. 1997. Eosinophilia and intracranial worm recovery in interleukin-5 transgenic and interleukin-5 receptor alpha chain-knockout mice infected with Angiostrongylus cantonensis. Parasitol Res. 83: 83-590.
Sumi Y., Dent M.A., Owen D.E., Seeley P.J., and Morris R.J. 1992. The expression of tissue and urokinase plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development. 116: 625-637.
Sumii T., and Lo E.H. 2002. Involvement of matrix metalloproteinase in thrombolysisassociated hemorrhagic transformation after embolic focal ischemia in rats. Stroke. 33: 831-836.
Tan H.K., Heywood D., Ralph G.S., Bienemann A., Baker A.H., and Uney J.B. 2003. Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons. Mol Cell Neurosci. 22: 98-106.
Teesalu T., Hinkkanen A.E., and Vaheri A. 2001. Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol. 159: 2227- 2237.
Tsai H.C, Lee S.S., Huang C.K., Yen C.M., Chen E.R., and Liu Y.C. 2004. Outbreak of eosinophilic meningitis associated with drinking raw vegetable juice in southern Taiwan. Am J Trop Med Hyg. 71: 222-226.
Tseng Y.K., Tu W.C., Lee H.H., Chen K.M., Chou H.L. and Lai S.C. 2004. Ultrastructural localization of matrix metalloproteinase-9 in eosinophils from the cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Ann Trop Med Parasitol. 98: 242-250.
Tsirka S.E., Rogove A.D., and Strickland S. 1996. Neuronal cell death and TPA. Nature. 384: 123-124.
Urban J.F. Jr, Madden K.B., Svetic A., Cheever A., Trotta P.P., Gause W.C., Katona I.M., and Finkelman F.D. 1992. The importance of Th2 cytokines in protective immunity to nematodes. Immunol Rev. 127: 205-220.
Valerius T., Repp R., Kalden J.R., and Platzer E. 1990. Effects of IFN on human eosinophils in comparison with other cytokines: a novel class of eosinophil activators with delayed onset of action. J Immunol. 145: 2950-2958.
Vassalii J.D., Sappino A.P., and Belin D. 1991. The plasminogen activator/plasmin system. J Clin Invest. 88: 1067-1072.
Verma R.P., and Hansch C. 2007. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem. 15:2223-2268.
Vermeulen M., van Vliet H.H., Lindsay K.W., Hijdra A., and van Gijn J. 1985. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage. J Neurosurg. 63: 573-577.
Waltz D.A., and Chapman H.A. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem. 269: 14746-14750.
Wan K.S., and Weng W.C. 2004. Eosinophilic meningitis in a child raising snails as pets. Acta Trop. 90: 51-53.
Wang X., Tsuji K., Lee S.R., Ning M., Furie K.L., Buchan A.M., and Lo E.H. 2004. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 35: 2726-2730.
Ware J.H., DiBennedetto A.J., and Pittman R.N. 1995. Localization of tissue plasminogen activator mRNA in the developing rat cerebellum and effects of inhibiting tissue plasminogen activator on granule cell migration. J Neurobiol. 28: 9-22.
Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M. V., and Chapman H.A. 1996. Regulation of integrin function by the urokinase receptor. Science. 273: 1551-1555.
Weinstein P.P., Rosen L., Laqueur G.L., and Sawyer T.K. 1963. Angiostrongylus cantonensis infection in rats and rhesus monkey, and observations survival of the parasite in vitro. Am J Trop Hyg. 12: 358-77.
William C.P., and Robert P.M. (ed) Matrix Metalloproteinases. 1998.
Winkler F., Kastenbauer S., Koedel U., and Pfister H.W. 2002. Role of the urokinase plasminogen activator system in patients with bacterial meningitis. Neurology. 59: 1350-1355.
Woessner J.F. 1991. Martix metalloprotienases and their inhibitor in connective tissue remodeling. FASEB J. 5: 145-53.
Wolburg H., and Lippoldt A. 2002. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 38: 323-337.
Yamaguchi Y., Suda T., Ohta S., Tominaga Miura Y., and Kasahara T. 1991. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 78: 2542-2547.
Yang E.V., Bane C.M., MacCallum R.C., Kiecolt-Glaser J.K., Malarkey W.B., and Glaser R. 2002. Stress-related modulation of matrix metalloproteinase expression. J Neuroimmunol. 133: 144-150.
Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., and Karin N. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against a4b1 integrin. Nature. 356: 63-66.
Yen C.M., Chen E.R., and Cheng C.W. 1990. A survey of Ampullarium canaliculatus for natural infection of Angiostrongylus cantonensis in south Taiwan. J Trop Med Hyg. 93: 347-50.
Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., and Lawrence D.A. 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest. 112: 1533-1540.
Yii C.Y. 1976. Clinical observations on eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis on Taiwan. Am J Trop Med Hyg. 25: 233-249.
Yii C.Y., Chen E.R., Hsieh H.C., Shih C.C., Cross J.H., and Rosen L. 1975. Epidemiologic studies of eosinophilic meningitis in Southern Taiwan. Am J Trop Med Hyg. 24: 447-54.
Yong V.W. 2005. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci. 6: 931-944.
Yoshimura K. 1993. Mechanism of parasite killing by eosinophils in parasitic infections. Nippon rinsho. 51: 657-663.
Yoshimura K., Aiba H., Oya H., and Yoshiro F. 1980. Angiostrongylus cantonensis: Development following pulmonary arterial transfers into permissive and nonpermissive hosts. Exp Parasitol. 49: 339-352.
Yoshimura K., Sugaya H., and Ishida K. 1994. The role of eosinophils in Angiostrongylus cantonensis infection. Parasitol Today. 10: 231-233.
Yoshimura K., Sugaya H., Kawamura K., and Kumagai M. 1988. Ultrastructural and morphometric analyses of eosinophils from the cerebrospinal fluid of the mouse and guinea-pig infected with Angiostrongylus cantonensis. Parasite Immunol. 10: 411-423.
Yurchenco P.D., and Schittny J.C. 1990. Molecular architecture of the basement membrane. FASEB J. 4: 1577-1590.
Zaman V., and Keong L.A. 1982. Handbook of medical parasitology. K C Ang Publishing Pte Ltd. pp166.
Zhang J.R., and Tuomanen E. 1999. Molecular and cellular mechanisms for microbial entery into the CNS. J Neurovirol. 5: 591-603.
Zhao B.Q., Tejima E, and Lo E.H. 2007. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke. 38: 748-52.
|